Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,948.00    4.00 (0.08%)
Bid:
4,956.00
Ask:
4,964.00
Spread: 8.00 (0.161%)
Market Cap: £2.31b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorship Changes

12 Dec 2023 07:00

RNS Number : 3963W
Morgan Sindall Group PLC
12 December 2023
 

 

12 December 2023

 

 

Morgan Sindall Group plc

 

Directorship changes

 

Morgan Sindall Group plc (the 'Company') today announces that Steve Crummett, Finance Director, has informed the Board of his intention to retire from the Company on 31 December 2024.

 

The Board also announces that following a search process, Kelly Gangotra, currently Chief Financial Officer, Healthcare Sector at Halma plc and previously Chief Financial Officer of Skanska UK, has been selected to succeed Steve as Finance Director.

 

Kelly will be appointed as Finance Director and become a member of the Board on a date to be agreed, expected to be around the third quarter of 2024, when Steve will step down from both roles. This will then allow for a period of transition until Steve retires from the Company at the end of the year.

 

John Morgan, Group Chief Executive Officer said: "I'd like to thank Steve for his exceptional contribution to the Board over the last ten years. Steve has seen the business through a period of significant growth and has helped shape our strategic direction and ensured that the financial stewardship of the business over the last 10 years has supported the Group's long term growth.

 

"I am delighted that Kelly will join the Group in 2024 and I look forward to working with her over the years ahead. She has an excellent track record as a CFO working in a decentralised business, is highly experienced in the construction and property industry and her valuable and significant skills and insight will support me and the Board as the Group continues to develop and grow." 

 

ENDS

A statement concerning particulars of remuneration payments in accordance with section 430(2B) of the Companies Act 2006 will be published in due course.

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

Kelly Gangotra

 

Kelly has extensive financial and commercial leadership experience across the construction and property sectors and has served as the CFO of the Healthcare division of Halma plc since August 2022. Prior to Halma, Kelly spent a decade with Skanska Plc in the UK where she was firstly Finance Director from 2012 to 2015 and then CFO and Executive Vice President between 2015 and 2022. She has also held senior finance roles at Alliance Medical and Biffa Waste Services.

 

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Kelly Gangotra.

 

 

 

Morgan Sindall Group

Michael Findlay (Chair)

John Morgan

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGAGPUPWGMG
Date   Source Headline
17th Nov 20167:00 amRNSMorgan Sindall awarded share of £300m HS2 contract
10th Nov 20162:25 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading Update
1st Nov 20162:26 pmRNSTotal Voting Rights
26th Oct 201610:40 amRNSBlock listing Interim Review
20th Oct 20168:30 amRNSAdditional Listing
3rd Oct 20167:00 amRNSAppointment of Chairman
30th Sep 201612:27 pmRNSTotal Voting Rights
31st Aug 201611:11 amRNSTotal Voting Rights
11th Aug 20167:15 amRNSHolding(s) in Company
11th Aug 20167:10 amRNSNotification of a transaction by PDMR
8th Aug 20164:56 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSDirectorate Change
2nd Aug 20167:00 amRNSHalf-year Report
29th Jul 201611:19 amRNSTotal Voting Rights
27th Jul 20169:28 amRNSHolding(s) in Company
25th Jul 20168:18 amRNSHolding(s) in Company
14th Jul 20168:49 amRNSHolding(s) in Company
8th Jul 201612:02 pmRNSPrice Monitoring Extension
30th Jun 20164:55 pmRNSDirector/PDMR Shareholding
30th Jun 20163:58 pmRNSTotal Voting Rights
29th Jun 20164:48 pmRNSDirector/PDMR Shareholding
22nd Jun 201611:22 amRNSHolding(s) in Company
14th Jun 20167:00 amRNSChange in Reporting Segments
31st May 201611:26 amRNSTotal Voting Rights
5th May 20164:03 pmRNSResult of AGM
5th May 20163:26 pmRNSResult of AGM
5th May 20167:00 amRNSAGM Trading Update
29th Apr 20161:04 pmRNSTotal Voting Rights
18th Apr 201610:13 amRNSBlock listing Interim Review
6th Apr 20161:25 pmRNSHolding(s) in Company
6th Apr 20168:40 amRNSDirector/PDMR Shareholding
31st Mar 20161:59 pmRNSTotal Voting Rights
24th Mar 201612:02 pmRNSAnnual Financial Report
3rd Mar 20164:30 pmRNSDirector/PDMR Shareholding
1st Mar 20169:24 amRNSTotal Voting Rights
26th Feb 20161:05 pmRNSDirector/PDMR Shareholding
23rd Feb 201612:16 pmRNSDividend Timetable and Home Member State
23rd Feb 20167:00 amRNSResults for the Full Year ended 31 December 2015
29th Jan 201612:01 pmRNSTotal Voting Rights
19th Jan 20161:52 pmRNSDirector Declaration
1st Dec 20151:40 pmRNSHolding(s) in Company
1st Dec 201511:52 amRNSTotal Voting Rights
10th Nov 201510:15 amRNSHolding(s) in Company
9th Nov 201510:30 amRNSDirectorate Change
2nd Nov 20157:00 amRNSTrading Update
30th Oct 20159:40 amRNSTotal Voting Rights
19th Oct 20159:50 amRNSBlocklisting Interim Review
25th Sep 201512:38 pmRNSDirector/PDMR Shareholding
14th Sep 20155:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.